Accordingly, whereas a study of 25 cases of breast cancer specimens, including hormone receptor-positive and -negative cases, reported that most tumors with high CDCP1 mRNA levels were positive for the proliferation marker Ki-67 [33], we found no association between CDCP1 expression and proliferation rates in our tumor series. Here, MKI67 is linked to breast carcinoma.